Evidence map›Paper›PMID 42305209›Full record

ArticleACS medicinal chemistry letters2026

Development of a High-Throughput Experimentation Workflow for Photochemical Reaction Screening.

Nam Nguyen, Colin Masui, Adam Childs, Andrew Barlow, Tao Chen, Malcolm P Huestis

Abstract read
In one paragraph

Article in ACS medicinal chemistry letters, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Nam NguyenSynthetic Molecule Analytical Chemistry, Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Colin MasuiSynthetic Molecule Analytical Chemistry, Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Adam ChildsSynthetic Molecule Analytical Chemistry, Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Andrew BarlowSynthetic Molecule Analytical Chemistry, Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.
Tao ChenSynthetic Molecule Analytical Chemistry, Synthetic Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.ORCID https://orcid.org/0000-0003-2725-6199
Malcolm P HuestisDiscovery Chemistry, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States.ORCID https://orcid.org/0000-0002-6038-3838

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Commercially available lab equipment was successfully integrated to enable visible-range photochemistry in a high-throughput 96-well screening format with magnetic stirring. Precise temperature control with maximal throughput was achieved by positioning the light source above the reaction mixtures and a cooling source below. This platform was benchmarked against other state-of-the-art commercial options using the Doyle-MacMillan reaction. Establishing a highly irradiated, temperature-controlled micromole-scale high-throughput experimentation (HTE) reaction screening protocol in a standard 96-well format could potentially accelerate modern reaction optimization in both medicinal and process chemistry.

Indexed as

96-well platehigh-throughput experimentationphotochemistryphotoredoxreaction optimization

Identifiers

PMID42305209
PMCPMC13266630

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.